These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 11821624)

  • 1. Impact of aldosterone on vascular pathophysiology.
    Struthers AD
    Congest Heart Fail; 2002; 8(1):18-22. PubMed ID: 11821624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical implications of aldosterone escape in congestive heart failure.
    Struthers AD
    Eur J Heart Fail; 2004 Aug; 6(5):539-45. PubMed ID: 15301999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aldosterone as a mediator in cardiovascular injury.
    Stier CT; Chander PN; Rocha R
    Cardiol Rev; 2002; 10(2):97-107. PubMed ID: 11895576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Aldosterone as an endogenous cardiovascular toxin and the options for its therapeutic management].
    Horký K
    Vnitr Lek; 2011 Dec; 57(12):1012-6. PubMed ID: 22277034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aldosterone and specific aldosterone receptor antagonists in hypertension and cardiovascular disease.
    Bravo EL
    Curr Hypertens Rep; 2003 Apr; 5(2):122-5. PubMed ID: 12642011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Insulin, renin-angiotensin system, aldosterone and endothelial dysfunction].
    Rubio-Guerra AF; Durán-Salgado MB
    Rev Med Inst Mex Seguro Soc; 2011; 49(6):581-4. PubMed ID: 22176818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Narrative review: the emerging clinical implications of the role of aldosterone in the metabolic syndrome and resistant hypertension.
    Sowers JR; Whaley-Connell A; Epstein M
    Ann Intern Med; 2009 Jun; 150(11):776-83. PubMed ID: 19487712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aldosterone: cardiovascular assault.
    Struthers AD
    Am Heart J; 2002 Nov; 144(5 Suppl):S2-7. PubMed ID: 12422134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular actions of aldosterone.
    Briet M; Schiffrin EL
    J Vasc Res; 2013; 50(2):89-99. PubMed ID: 23172373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aldosterone in heart and kidney diseases.
    Rentoukas EI; Lazaros GA; Zirogiannis PN
    Hellenic J Cardiol; 2005; 46(6):408-19. PubMed ID: 16422128
    [No Abstract]   [Full Text] [Related]  

  • 11. Aldosterone and vascular damage.
    Duprez D; De Buyzere M; Rietzschel ER; Clement DL
    Curr Hypertens Rep; 2000 Jun; 2(3):327-34. PubMed ID: 10981167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of aldosterone and mineralocorticoid receptor blockade on vascular inflammation.
    Joffe HV; Adler GK
    Heart Fail Rev; 2005 Jan; 10(1):31-7. PubMed ID: 15947889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving vascular function in hypertension: potential benefits of combination therapy with amlodipine and renin-angiotensin-aldosterone system blockers.
    Siragy HM
    J Hypertens; 2010 Jan; 28(1):2-8. PubMed ID: 19797978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aldosterone-induced vasculopathy.
    Struthers AD
    Mol Cell Endocrinol; 2004 Mar; 217(1-2):239-41. PubMed ID: 15134823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RAAS escape: a real clinical entity that may be important in the progression of cardiovascular and renal disease.
    Lakkis J; Lu WX; Weir MR
    Curr Hypertens Rep; 2003 Oct; 5(5):408-17. PubMed ID: 12948434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The renin-angiotensin-aldosterone system and myocardial collagen matrix remodelling in congestive heart failure.
    Brilla CG; Rupp H; Funck R; Maisch B
    Eur Heart J; 1995 Dec; 16 Suppl O():107-9. PubMed ID: 8682074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Aldosterone and cardiovascular diseases, more than water and salt retention].
    Duprez D
    Verh K Acad Geneeskd Belg; 2002; 64(3):225-32. PubMed ID: 12238244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aldosterone and end-organ damage.
    Marney AM; Brown NJ
    Clin Sci (Lond); 2007 Sep; 113(6):267-78. PubMed ID: 17683282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of Renin-Angiotensin-Aldosterone System Activation in Promoting Cardiovascular Fibrosis and Stiffness.
    Jia G; Aroor AR; Hill MA; Sowers JR
    Hypertension; 2018 Sep; 72(3):537-548. PubMed ID: 29987104
    [No Abstract]   [Full Text] [Related]  

  • 20. Aldosterone and heart failure.
    Zannad F
    Eur Heart J; 1995 Dec; 16 Suppl N():98-102. PubMed ID: 8682070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.